Pharmacological tuning of microRNAs in FAP-derived Extracellular Vesicles by HDAC inhibitors promotes regeneration and reduces fibrosis in dystrophic muscles
Authors:
- Martina SandonaMSMartina Sandona
- Silvia ConsalviSCSilvia Consalvi
- Luca TucciaroneLTLuca Tucciarone
- Marco De BardiMBMarco De Bardi
- Manuel ScimecaManuel Scimeca
- Daniela Francesca AngeliniDADaniela Francesca Angelini
- Valentina BuffaVBValentina Buffa
- Adele D'AmicoADAdele D'Amico
- Enrico Silvio BertiniEBEnrico Silvio Bertini
- Sara CazzanigaSCSara Cazzaniga
- Paolo BetticaPBPaolo Bettica
- Marina BoucheMarina Bouche
Preprint
Abstract
Functional interactions between cellular components of the muscle stem cell (MuSC) niche regulate the regenerative ability of skeletal muscles in physiological and pathological conditions; however, the identity of the mediators of these interactions remains largely unknown. We show here that fibro-adipogenic progenitor (FAP)-derived Extracellular Vesicles (EVs) mediate microRNA transfer to MuSCs, and that exposure of dystrophic FAPs to HDAC inhibitors (HDACi) increases the intra-EV levels of a subset of microRNAs (miRs), which cooperatively target biological processes of therapeutic interest, including regeneration, fibrosis and inflammation. In particular, we found that increased levels of miR206 in EVs released from FAPs of muscles from Duchenne dystrophic patients or mice (mdx) exposed to HDACi were associated with enhanced regeneration and inhibition of fibrosis of dystrophic muscles. Consistently, EVs from HDACi-treated dystrophic FAPs could stimulated MuSC activation and expansion ex vivo, and promoted regeneration, while inhibiting fibrosis and inflammation of dystrophic muscles, upon intramuscular transplantation, in vivo. These data reveal a potential for pharmacological modulation of FAP-derived EV’s content as novel strategy for focal therapeutic interventions in Duchenne Muscular Dystrophy (DMD) and possibly other muscular diseases. Brief Summary: Extracellular Vesicles from HDACi-treated dystrophic FAPs promote regeneration, while inhibiting fibrosis and inflammation of dystrophic musclesKeywords
This publication has 62 references indexed in Scilit:
- The central role of muscle stem cells in regenerative failure with agingNature Medicine, 2015
- Interactions between muscle stem cells, mesenchymal-derived cells and immune cells in muscle homeostasis, regeneration and diseaseCell Death & Disease, 2015
- Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro/adipogenic progenitorsNature Medicine, 2015
- Cellular dynamics in the muscle satellite cell nicheEMBO Reports, 2013
- Regeneration versus fibrosis in skeletal muscleCurrent Opinion in Rheumatology, 2011
- Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscleJournal of Cell Science, 2011
- Mechanisms of Muscle Injury, Repair, and Regeneration2011
- Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscleNature Cell Biology, 2010
- Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesisNature Cell Biology, 2010
- SATELLITE CELL OF SKELETAL MUSCLE FIBERSJournal of Cell Biology, 1961